


<rss version="2.0">
<channel>
<title>JCO Highlighted Sarcoma Articles</title><link>http://jco.ascopubs.org/</link><description>American Society of Clinical Oncology (ASCO)</description><image><url>http://www.asco.org/images/ascorss.gif</url><title>JCO Highlighted Sarcoma Articles</title><link>http://jco.ascopubs.org/</link></image><item><title><![CDATA[Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/27/20/3391]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/26/34/5583]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Outcome After Surgical Resections of Recurrent Chest Wall Sarcomas]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/26/31/5113]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Allogeneic Hematopoietic Stem-Cell Transplantation for Myeloid Sarcoma: A Retrospective Study From the SFGM-TC]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/26/30/4940]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/26/4/626]]></link><description> <![CDATA[]]></description></item><item><title><![CDATA[Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing <it>KIT</it>]]></title><link><![CDATA[http://www.asco.org:80/portal/jsp/asco/singlesignon/ascopubs_login.jsp?ascopubs_url=http://www.jco.org/cgi/content/full/26/4/620]]></link><description> <![CDATA[]]></description></item>
</channel>
</rss>



